{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/asthma/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"053272da-fea9-5df6-842a-0de682896aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 9fb10e3b-96c1-477c-a385-a6b9011a92f9 --><h2>What are the differential diagnoses of asthma?</h2><!-- end field 9fb10e3b-96c1-477c-a385-a6b9011a92f9 -->","summary":"","htmlStringContent":"<!-- begin item d2ef7678-6881-4a6c-bd0e-a6b9011a90ba --><!-- begin field db843229-ef58-423b-860a-a6b9011a92f9 --><p><strong>The differential diagnoses of asthma include:</strong></p><ul><li><strong>Bronchiectasis </strong>— clinical features include copious sputum, frequent chest infections, a history of childhood pneumonia, and coarse lung crepitations. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/bronchiectasis/\">Bronchiectasis</a>.</li><li><strong>Chronic obstructive pulmonary disease (COPD) </strong>— asthma and COPD can be difficult to distinguish clinically and may co-exist. Clinical features of COPD include a productive cough and dyspnoea on exertion in a person over 35 years of age who is a current or previous smoker. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-obstructive-pulmonary-disease/\">Chronic obstructive pulmonary disease</a>.</li><li><strong>Ciliary dyskinesia </strong>— clinical features include persistent moist cough present from birth.</li><li><strong>Cystic fibrosis </strong>— clinical features include persistent moist cough and gastrointestinal symptoms that are often present from birth, finger clubbing, and failure to thrive in children.</li><li><strong>Dysfunctional breathing </strong>— clinical features include breathlessness, dizziness, light-headedness, and peripheral tingling.</li><li><strong>Foreign body aspiration</strong> — suggested by sudden-onset cough, stridor (upper airway) or reduced chest wall movement on the affected side, bronchial breathing, and reduced or diminished breath sounds (lower airway).</li><li><strong>Gastro-oesophageal reflux </strong>— clinical features include cough, postural and food-related symptoms, and vomiting. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-proven-gord/\">Dyspepsia - proven GORD</a>.</li><li><strong>Heart failure</strong> — clinical features include orthopnoea, oedema, a history of ischaemic heart disease, and fine lung crepitations. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a>.</li><li><strong>Interstitial lung disease </strong>(asbestosis, pneumoconiosis, fibrosing alveolitis, sarcoidosis) — clinical features include a dry cough and fine lung crepitations.</li><li><strong>Lung cancer</strong> — clinical features include persistent cough, haemoptysis, weight loss, or persistent hoarse voice. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/\">Lung and pleural cancers - recognition and referral</a>.</li><li><strong>Pertussis </strong>— clinical features include paroxysms of coughing. There may be vomiting after coughing, or an inspiratory whoop (especially in children, although this may be absent in infants). Occasionally the cough may persist for several months. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/whooping-cough/\">Whooping cough</a>.</li><li><strong>Pulmonary embolism (PE)</strong> — suggested by acute-onset breathlessness, pleuritic pain, haemoptysis, crackles, and sinus tachycardia. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pulmonary-embolism/\">Pulmonary embolism</a>.</li><li><strong>Tuberculosis</strong> — clinical features include persistent productive cough, which may be associated with breathlessness and haemoptysis. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a>.</li><li><strong>Upper airway cough syndrome </strong>— clinical features include frequent throat clearing and associated symptoms of chronic sinusitis (nasal blockage or discharge with facial pain or pressure over the affected sinus) or allergic rhinitis (nasal itching, sneezing, discharge, and blockage). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cough/\">Cough</a>.</li><li><strong>Vocal cord dysfunction </strong>— clinical features include dyspnoea and stridor.</li></ul><p>For detailed information on the differential diagnosis of people with cough or breathlessness, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/cough/\">Cough</a> and <a class=\"topic-reference external-reference\" href=\"/topics/breathlessness/\">Breathlessness</a>.</p><p>If there is a low probability of asthma and/or an alternative diagnosis is more likely, investigate for the alternative diagnosis, reconsidering asthma if the clinical picture changes or an alternative diagnosis is not confirmed. If reconsidering asthma, undertake or refer for further tests to investigate for a diagnosis of asthma.</p><!-- end field db843229-ef58-423b-860a-a6b9011a92f9 --><!-- end item d2ef7678-6881-4a6c-bd0e-a6b9011a90ba -->","topic":{"id":"d631356f-d3a3-51fb-807c-5517c470a5af","topicId":"2a0a90e6-1c4e-4b6a-9ce2-3379dd122594","topicName":"Asthma","slug":"asthma","lastRevised":"Last revised in October 2020","chapters":[{"id":"c7185669-75fd-5c6e-b105-63a3237634ac","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9fe1ab10-4b4d-5ba8-9ef0-00631cd00ea4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"770d55df-2c61-5d1e-83d9-92b12ccae96a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d2031db2-44fd-55bb-b5c8-d085b387747a","slug":"changes","fullItemName":"Changes"},{"id":"a993bde1-1ac8-529e-8a3e-201a8c082ab2","slug":"update","fullItemName":"Update"}]},{"id":"eae8fe92-3941-512e-bcc6-f1e15157c1ae","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8e125759-cd9d-510d-9659-3c2e77baa755","slug":"goals","fullItemName":"Goals"},{"id":"a6c91cd5-1ce2-5c60-86cc-341a9dccf3d4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a5746054-2f36-5a42-9e7c-7af9107ad99b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5fd19cd9-6ac7-54c8-89be-817d58e41309","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f7339086-c653-53dd-990c-6d470fa223b8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f43b79db-3c62-58ee-bb70-932e6613eea6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0d12a387-5436-5c75-92c0-189cb391ec7a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8fbe04ed-5fd7-54c9-be84-6c959f75af3b","slug":"definition","fullItemName":"Definition"},{"id":"5cbe6206-f80c-5a71-8e4d-a4d44e392874","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2fb588ab-6181-5aec-8a4a-fb368098329d","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b786654f-5e6e-5e5f-9ead-abaca7f99ba5","slug":"prognosis","fullItemName":"Prognosis"},{"id":"c0b65c0b-957e-538e-83e9-5b4af2d8e6dd","slug":"complications","fullItemName":"Complications"}]},{"id":"574c6193-f36f-5bf7-946a-d8c688476131","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"351773e5-286c-5560-8402-79c2d92d4aa6","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"053272da-fea9-5df6-842a-0de682896aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"7b632c20-012f-590e-a01e-cda5715d6f14","fullItemName":"Management","slug":"management","subChapters":[{"id":"f95fb73f-b749-53a5-b857-4d2bb9945667","slug":"newly-diagnosed-asthma","fullItemName":"Scenario: Newly-diagnosed asthma"},{"id":"2878c5f8-3e3f-52c8-a9bd-7988906b6f99","slug":"follow-up","fullItemName":"Scenario: Follow-up"},{"id":"2458c073-8efb-5a81-8bc4-9a543deab17d","slug":"acute-exacerbation-of-asthma","fullItemName":"Scenario: Acute exacerbation of asthma"},{"id":"45a1b06c-1e5d-56b4-8da7-a8abf4f6c7cc","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"fb9dc424-4306-54a1-b06b-1b01273ac473","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"52940123-8084-55c3-b593-cc9fe50daf8f","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"5eb1288c-29af-59c1-b623-bd0010732835","slug":"beta-2-agonists","fullItemName":"Beta-2 agonists"},{"id":"dc8f7545-ff7a-5bf1-8ac8-95161137fac5","slug":"inhaled-corticosteroids","fullItemName":"Inhaled corticosteroids"},{"id":"4d715496-c821-52e3-8ea0-d05cfb33d3eb","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"},{"id":"d8174f33-d787-5076-88b5-f4c67df93128","slug":"leukotriene-receptor-antagonists","fullItemName":"Leukotriene receptor antagonists"},{"id":"a556cd4f-1851-52fd-a993-34e977a27fd2","slug":"muscarinic-agents","fullItemName":"Muscarinic agents"},{"id":"0cea3b69-b77b-505e-bded-6fceaca145df","slug":"theophylline","fullItemName":"Theophylline"},{"id":"550429f1-7cab-5f16-b476-e479d8084c03","slug":"cromones","fullItemName":"Cromones"}]},{"id":"76b3dfce-ba54-5456-a259-79b345a5e064","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e31b3681-17cc-5ff2-ba28-d3b1fcb0a82c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2bcf3eeb-fd2e-5d40-a52f-da626afbbe01","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"14ea4312-4846-5381-a82c-dc6b03a60d04","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e4987bc8-0a78-59eb-bfda-f9de7c9ee182","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"be4f3045-8192-53b7-81a3-b460bb2218bc","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"82ae443c-942c-5053-a988-38bce8dec570","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"efdf3cf8-dee5-5351-9d2d-346b4fdf9faf","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"574c6193-f36f-5bf7-946a-d8c688476131","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"90de8117-7652-5f9a-a478-c71aed891080","slug":"basis-for-recommendation-cca","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 4e0de4e7-332c-4933-94e5-a6be01015ee8 --><h3>Basis for recommendation</h3><!-- end field 4e0de4e7-332c-4933-94e5-a6be01015ee8 -->","summary":null,"htmlStringContent":"<!-- begin item ccaa6389-5575-419c-94c5-a6be01015e7c --><!-- begin field fda48776-5063-4bba-a2d0-a6be01015ee8 --><p>The information on differential diagnoses of asthma are based on expert opinion in the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) <em>British guideline on the management of asthma </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/asthma/references/\">BTS/SIGN, 2019</a>], and the Global Initiative for Asthma (GINA) guideline on <em>Global strategy for asthma management and prevention </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/asthma/references/\">GINA, 2016</a>]<em>. </em></p><!-- end field fda48776-5063-4bba-a2d0-a6be01015ee8 --><!-- end item ccaa6389-5575-419c-94c5-a6be01015e7c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}